Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease

Area of Science:

• Pulmonology
• Rheumatology
• Immunology

Background:

• Microscopic polyangiitis (MPA), a small vessel vasculitis, can present with atypical respiratory manifestations.
• Pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) are unusual but recognized complications of MPA.

Observation:

• This report details two cases of MPA with significant pulmonary involvement, including pulmonary fibrosis in both patients and COPD in one.
• Patients received standard immunosuppressive therapies such as methylprednisone, prednisone, cyclophosphamide, and azathioprine.

Findings:

• Both patients showed initial positive responses to immunosuppressive treatment for their MPA.
• However, the pulmonary manifestations, specifically pulmonary fibrosis and COPD, proved refractory to the immunosuppressive regimens.

Implications:

• MPA should be considered in unexplained respiratory conditions, including pulmonary fibrosis and COPD, to ensure timely diagnosis and management.
• Pulmonary involvement in MPA may necessitate long-term management strategies due to its potential refractoriness to standard immunosuppression.